TITLE

Medical microbiology

PUB. DATE
August 1997
SOURCE
Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS56
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
Presents an abstract of the research manuscript `Risk reduction of mother-to-child HIV transmission by antiretroviral therapy in a clinical setting,' by N. Lapointe et al. Zidovudine treatment.
ACCESSION #
9708236590

 

Related Articles

  • If you're positive, take AZT.  // Joe Weider's Muscle & Fitness;May95, Vol. 56 Issue 5, p48 

    Reports that AZT drug therapy can reduce the risk for mother-to-child HIV transmission. Legal and ethical concerns of AZT drug therapy.

  • Short-course zidovudine in perinatal HIV transmission.  // WHO Drug Information;1999, Vol. 13 Issue 1, p6 

    Reports on clinical trials of short-course zidovudine use in perinatal human immunodeficiency virus (HIV) transmission. Reduction of the risk of transmission; Need to identify HIV infected women who do not receive zidovudine during pregnancy.

  • DECLINE IN VERTICAL TRANSMISSION.  // AIDS Patient Care & STDs;Nov2000, Vol. 14 Issue 11, p615 

    Reports on the decline in the vertical transmission rates of HIV in the United States. Rate decline from 1990 to 1997; Role of the routine use of azidothymidine in HIV-infected pregnant women in the decline.

  • Short-course zidovudine in perinatal HIV transmission: more evidence and debate.  // WHO Drug Information;1999, Vol. 13 Issue 2, p65 

    Describes the use of short-course zidovudine in perinatal HIV transmission. Role of elective cesarean section in prevention of HIV transmission; Efficacy of zidovudine in breast-feeding women; Difficulties in HIV counselling and testing and drug management during labor.

  • An affordable HIV regimen. Althaus, Frances // International Family Planning Perspectives;Jun98, Vol. 24 Issue 2, p54 

    Reports on the use of the antiretroviral drug zidovudine for HIV-infected pregnant women to lower the rate of perinatal HIV transmission from mother to infant. Feasibility of the regimen for implementation in developing countries.

  • Successful Implementation of Perinatal HIV Prevention Guidelines. Wortley, Pascale M.; Lindegren, Mary Lou; Fleming, Patricia L. // MMWR: Morbidity & Mortality Weekly Report;5/11/2001Supplement RR-6, Vol. 50 Issue 18, p15 

    Presents information on a study which evaluated the implementation of guidelines regarding the use of zidovudine to reduce perinatal transmission of the human immunodeficiency virus. Methodology of the study; Results and discussion on the study; Conclusion.

  • Study shows Retrovir can prevent mother-to-infant HIV transmission.  // New York Amsterdam News;11/12/94, Vol. 85 Issue 46, p14 

    Reports on the preliminary results of a study on the treatment of HIV-infected women and their newborns with Retrovir. Reduction of the risk of maternal-to-fetal transmission of the virus; Food and Drug administration's approval of the drug for the indication; Study protocol.

  • Vertical transmission: Now preventable. Legg, Jill J.; Minkoff, Howard S. // Patient Care;5/15/1996, Vol. 30 Issue 9, p160 

    Reports that mother-to-infant transmission of AIDS is preventable with zidovudine therapy. AIDS in children in the United States as attributable to perinatal transmission of HIV; Maternal risk factors; Use of AZT.

  • Cost-Effective HIV Prevention. Althaus, Frances // International Family Planning Perspectives;Sep98, Vol. 24 Issue 3, p102 

    Reports on a cost-effective HIV prevention measure proposed for Sub-Saharan Africa. Prevention of perinatal transmission of the virus from mother to child through a short course of zidovudine given to pregnant, HIV-infected women; Cost analysis.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics